CARR EDWARD
CHIEF ACCOUNTING OFFICER · 8 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 23,465 | $81.75 | $1.9M | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 15,852 | $80.71 | $1.3M | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 17,500 | $22.07 | $386,225.00 | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 3,865 | $82.66 | $319,480.90 | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 16,182 | $17.88 | $289,334.16 | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 10,000 | $21.77 | $217,700.00 | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 300 | $85.53 | $25,659.00 | filing |
| 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 200 | $83.38 | $16,676.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.